MicroRNA-381 • Leucine-rich repeat C4 protein • Stromal cell-derived factor-1/CXC chemokine receptor-4 signaling pathway • Cerebral lymphatic blockage • Acute cerebral ischemia • Repair of nerve injury Abstract Background/Aims: Acute cerebral ischemia is a manifestation of cerebral vascular insufficiency and has a high mortality. However, the therapy for acute cerebral ischemia is still limited. This study aimed to investigate the effect of microRNA-381 (miR-381) on the repair of nerve injury in rats with acute cerebral ischemia after cerebral lymphatic blockage (CLB) by targeting leucine-rich repeat C4 protein (LRRC4) through the Stromal cell-derived factor-1/CXC chemokine receptor-4 signaling pathway. Methods: Rat models of CLB and middle cerebral artery occlusion (MCAO) were established, and 56 Wistar rats were divided into sham, MCAO, CLB + MCAO, CLB + MCAO + miR-381 inhibitor, CLB + MCAO + miR-381 mimic, CLB + MCAO + AMD3100 and CLB + MCAO + miR-381 mimic + AMD3100 groups. Modified neurological severity score (mNSS was used to determine nerve injury, TTC staining to measure infarction volume, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining and flow cytometry to evaluate cell apoptosis, immunofluorescence to measure BrdUpositive cell number, enzyme-linked immunosorbent assay (ELISA) to determine contents of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), nerve growth factor (NGF) and neurite outgrowth inhibitor -A (Nogo-A), Reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blotting to evaluate expression of miR-381, LRRC4, SDF-1, CXCR4, pERK, Slit2 and vascular endothelial growth factor (VEGF). Results: LRRC4 was a target gene of miR-381. Compared with the results in the CLB + MCAO group, mNSS, infarction volume, apoptosis rate and TNF-α, IL-1β, IL-6 and Nogo-A contents as well as LRRC4 expression in the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups were increased (those in the CLB + MCAO + AMD3100 group > those in the CLB + MCAO + miR-381 mimic + AMD3100 group), while BrdU-positive cell number, contents of NGF and IL-10, and expression of SDF-1, CXCR4, pERK, Slit2 and VEGF in brain tissues were decreased (those in the CLB + MCAO + AMD3100 group < those in the CLB + MCAO + miR-381 mimic + AMD3100 group). The results in the CLB + MCAO + mimic group were opposite of those in the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups. Conclusion: Taken together, we concluded that up-regulation of miR-381 promoted nerve injury repair in acute cerebral ischemia rats after CLB by negatively regulating LRRC4 through activating the SDF-1/CXCR4 signaling pathway.
Introduction
Cerebral vascular insufficiency is called cerebral ischemia, which can lead to a lack of oxygen and brain death, accompanied by extensive pathophysiological processes; cerebral vascular insufficiency is divided into two main types, chronic cerebral ischemia and acute cerebral ischemia [1, 2] . Cerebral ischemia has exerted a great effect on society, leading to high mortality rates and temporarily and permanently incapacitated survivors. Cerebral vascular insufficiency is most commonly caused by transient cardiac arrest, severe arrhythmias, and cerebral arterial occlusion (such as thrombosis and embolism) [3] . The prevention or treatment of some risk factors, mainly hypertension, coronary artery disease, myocardial infarction, dyslipidemia and atherosclerosis, has been put forward with the aim of reducing the prevalence of ischemic brain disease [4] . Most ischemic situations occur in the middle cerebral artery, but there are many clinical variants related to vascular disease [5] . There are many treatments to treat acute cerebral ischemia, such as agents and intraarterial therapy, but no single therapy can provide the best curative effect [6, 7] . However, evidence has demonstrated that microRNAs (miRs) are key targets involved in neuronal development and injured tissue repair and remodeling; miRs are also a new treatment tool for cerebral ischemia [8, 9] . miRs are an evolutionarily conserved, 20-22 nucleotide noncoding RNA family. They regulate gene expression by binding to complementary sequences in the 3' untranslated region (UTR) of their target miRs [10, 11] . Recently, research has shown that miRs are correlated with stroke pathogenesis, contributing to the effects of neural cell survival and stroke-mediated inflammation; they are also involved in vascular function, angiogenesis, neural function, and acute hypoxia [12] . In addition, microRNA-381 (miR-381), a neuronal miR, is overexpressed in the mature brain and normal hippocampal neurons [13] . The interaction of miR-381 and leucine-rich repeat C4 protein (LRRC4) participates in glioma growth, and LRRC4 acts as a target gene of miR-381 [14] . Additionally, LRRC4 is a brainspecific gene that has also been regarded as a tumor suppressor gene in glioma, and hsamiR-381 targets LRRC4 [15] . A previous study revealed multiple functions of the SDF-1/ CXCR4 signaling pathway in modulating neo-vascularization during acute ischemia [16] . Furthermore, the SDF-1/CXCR4 chemokine receptor system played a double role in the brain: isoform-selective regulation of SDF-1 expression regulated CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia [17] . Thus, miR-381, LRRC4 and the SDF-1/CXCR4 signaling pathway may make a great difference in neuronal progression. Therefore, in this study we aimed to investigate the effect of miR-381 and its target gene LRRC4 through the SDF-1/CXCR4 signaling pathway on the repair of nerve injury in rats with acute cerebral ischemia after cerebral lymphatic blockage (CLB).
Materials and Methods

Ethics statement
The study was approved by the Ethics Committee of The First Hospital of Jilin University, and all experiments were in accordance with the Helsinki declaration.
Dual luciferase reporter gene assay
MicroRNA.org was used to predict the possible target genes of miR-381. Genomic DNA extraction from 293T cells (human embryonic kidney cells) (GDC187, Wuhan Cell Bank, Wuhan, China) was performed in accordance with the TIANamp Genomic DNA Kit (TIANGEN Biotechnology Co. Ltd, Beijing, China) instructions, and LRRC4-3'-untranslated region-wild type (LRRC4-3'-UTR-wt) and LRRC4-3'-untranslated region-mutant type (LRRC4-3'-UTR-mut) constructs without the miR-381-binding site were designed. A luciferase reporter vector was constructed, and 293T cells were transfected with a miR-381 mimic, which was synthesized by Shanghai Sangon Biotech Co., Ltd. (Shanghai, China). The measurement of luciferase activity was performed using a dual luciferase reporter gene assay reagent (E1910, Promega Corporation, Madison, WI, USA). After transfection for 48 h, the previous culture medium was removed, and samples were washed with phosphate-buffered saline (PBS) twice. Then, 100 μl of passive lysis buffer (PLB) was added to the cells in each well, which were shaken slightly for 15 min at room temperature. The cell lysis buffer was collected. The program was set to pre-read for 2 s and read the value for 10 s, and the injection volume of LARIIStop&Glo ® Reagent (E1910, Promega Corporation, Madison, WI, USA) was 100 μl. The prepared LARIIStop&Glo ® Reagent added into the cell lysate in the luminous tubes or plates (20 μl of each sample) was measured by a bioluminescence detection instrument (Modulus™; American TurnerBioSystems Company, Sunnyvale, CA, USA). The fluorescence activity of firefly luciferase (LUC) and Renilla luciferase (RL) was detected, and the latter indicated the transfection efficiency of each well. The ratio of both was the relative luciferase expression, which was expressed as LUC/RL.
Model establishment
The Casley-Smith method was used to establish the rat models of CLB [18] . Specific methods were as follows: the rats were anesthetized by intraperitoneal injection of 1% pentobarbital sodium (30 mg/kg), fixed on the operating table in a supine position, and sheared and disinfected. Under aseptic conditions, the superficial cervical lymph nodes in both sides of the rats were separated, and the lymph nodes were removed after the afferent and efferent lymph vessels were ligated with padded silk NO. 1. The subcutaneous tissue and muscular layers were separated layer by layer until the trachea was uncovered. The muscles of both sides of the trachea and thyroid cartilage were carefully separated. The deep cervical lymph nodes were then isolated from the side of thyroid cartilage and the posterolateral portion of the common carotid artery and posterolateral vagus nerve (1 -2 for each), and the lymphatic vessels of both sides were ligated using the same method. After the deep cervical lymph nodes were removed, the incisions were sutured layer by layer. At one day after the establishment of the rat model of CLB, the middle cerebral artery occlusion (MCAO) model was constructed [19] . Rats were anesthetized by intraperitoneal injection of 1% pentobarbital sodium (30 mg/kg) and fixed in a supine position. The left common carotid artery (CCA), the external carotid artery (ECA) and the internal carotid artery (ICA) were exposed and isolated. After temporary occlusion of the CCA and ICA, the glass fiber was inserted into the centripetal end of the ECA, and then the ICA was inserted into the CCA bifurcation. When the ICA went in approximately 19 mm, resistance was obviously felt with the bending of the extracranial ICA, which showed that the glass fiber tip reached the origin of the middle cerebral artery (MCA). Then, the blood vessels and the fibers inserted into the blood vessels were ligated together. After 2 h of ischemia, the thread that was used to ligature the blood vessel was loosened to perform reperfusion [20, 21] . After that, the incision was sutured. In the sham group, the lymphatic vessels were not ligated, the lymph nodes were not removed, and the acute cerebral ischemia was not treated. The other operation procedures were the same as those in the experimental group. The Zea Longa score [22] was used to identify whether the model was successfully constructed: rats with behavioral score > 1 were regarded as successfully constructed models, and rats with behavioral score between 2 and 3 were divided into groups. The standards of the scores on the 5-point scale were as follows: score of 0, rats had no obvious neurological deficits; score of 1, rats failed to fully extend the left forepaw when they were held upside down; score of 2, rats circled to the contralateral side; score of 3, rats exhibited difficulty walking and leaned towards the contralateral side; score of 4, rats failed to spontaneously walk and were not conscious.
Animal grouping
A total of 56 healthy Wistar rats were selected, with no limitation of sex, and the body weight was 260 ~ 320 g. Rats were provided by Gansu University of Chinese Medicine Research Laboratory Animal Center (license number: SCXK (Gan) 2015-0005). All rats were divided into 7 groups (n = 8): sham group (rats without MCAO or CLB), MCAO group (rat models of MCAO), CLB + MCAO group (rat models of MCAO after CLB), CLB + MCAO + miR-381 inhibitor group (before the establishment of the MCAO model, the miR-381 inhibitor was dissolved in artificial cerebrospinal fluid and injected into the lateral ventricles at 0.6 mg/kg injection volume), CLB + MCAO + miR-381 mimic group (before the establishment of the MCAO model, the miR-381 mimic was dissolved in artificial cerebrospinal fluid at a concentration of 20 μmol/l and injected into the lateral ventricles at 0.6 mg/kg injection volume), CLB + MCAO + AMD3100 group (AMD3100 {155148-31-5; Medchem, Express, Jersey, USA}, a receptor antagonist for CXCR4; after the establishment of the CLB + MCAO model, AMD3100 was immediately injected intraperitoneally at a dose of 1 mg/kg), CLB + MCAO + miR-381 mimic + AMD3100 group (before the establishment of the MCAO model, the miR-381 inhibitor was dissolved in artificial cerebrospinal fluid and injected into the lateral ventricles at 0.6 mg/kg injection volume; after the establishment of the CLB + MCAO model, AMD3100 was immediately injected intraperitoneally at a dose of 1 mg/kg).
Modified neurological severity score (mNSS)
Twenty-four hours after the MCAO operation, the mNSS was used to determine the nerve injury of rats [23] . mNSS is the evaluation standard for rat movement, reflex, sensation and balance; the minimum score was 0, and the maximum score was 18. Evaluation standard: scores 1 ~ 6, mild injury; scores 7 ~ 12, moderate injury; scores 13 ~ 18, severe injury.
2, 3,5-triphenyltetrazolium chloride (TTC) staining
Twenty-four hours after the MCAO operation, the rats were anesthetized by intraperitoneal injection of 1% pentobarbital sodium (30 mg/kg), and the blood was rapidly washed by rapid perfusion of the heart with 100 ml of normal saline that was pre-cooled at 4°C. The rats were decapitated, and the brain was quickly dissected on ice, with removal of the cerebellum, olfactory bulb, and lower brain stem; only the brain was left, and its length was measured. After the forebrain was frozen at -20°C for 10 min, it was isolated on the ice plate and sliced into 2-mm serial sections starting from the antinion, resulting in approximately 6 ~ 8 pieces [24] . Then, the sections were put into 2% TTC solution (2530-85-0, Guidechem, Shanghai, China), incubated in the dark at 37°C for 30 min (the sections were flipped during incubation to ensure uniform staining), fixed in 4% paraformaldehyde phosphate overnight and observed. The staining resulted in normal brain tissues stained red and necrotic brain tissues stained white. The results were recorded by a digital camera (type: 5D Mark III; Canon Inc., Tokyo, Japan), and each group had 3 replicates. A correction of advanced edema volume was performed before calculating the volume of cerebral infarction [24] : the rats were decapitated, and the brain was quickly dissected. The fresh tissue samples were immediately weighed on pre-weighed aluminum foil to obtain the wet weight. Then, the tissues were dried for 24 h in an electronic oven at 105°C, and the dry tissue was weighed. Water content was expressed as (wet weightdry weight)/wet weight × 100%. The volume of cerebral infarction was calculated as follows: the infarction volume of each brain section was determined by an image analyzer (Bio-Rad Laboratories Inc., Hercules, CA, USA), and the infarction volume was calculated by summing the infarction volume measured in each section. The total infarction volume was expressed as a percentage of the total cerebral infarction volume of the right brain [24] .
Hematoxylin-eosin (HE) staining
Twenty-four hours after MCAO operation, the brain tissues of rats in each group were selected, fixed with 4% formaldehyde for 6 h, and embedded in paraffin. The paraffin-embedded brain tissues were cut into 3-μm-thick sections, baked at 60°C overnight, dewaxed with xylene I (14936-97-1, Shanghai Research Biological Technology Co., Ltd., Shanghai, China) and xylene II (CAS number: 523-67-1; Shanghai Yuduo Biotechnology Co., Ltd., Beijing, China) for 20 min, respectively, and put into distilled water after soaking in 100%, 100%, 95%, 80%, and 70% ethanol for 5 min each. Then, sections were stained with hematoxylin for 10 min (474-07-7, Qingdao Jisskang Biotechnology Co., Ltd., Qingdao, China) and washed with water for 15 min to turn the sections blue. After the sections were stained with eosin for 30 s (RY0648, Qingdao Jisskang Biotechnology co., Ltd., Qingdao, China), they were washed with double-distilled water. Then, the sections were dehydrated with alcohol, cleared in xylene and mounted with neutral balsam. The morphological image analysis system (JD801; Jeda Technology Co. Ltd., Nanjing, China) revealed the morphological changes of neurons in the rat brain sections from different groups after HE staining (× 400), and the images were randomly collected. The experiment was repeated three times.
Terminal deoxynucleotidyl transferase (TdT)-mediated (dUTP) nick end-labeling (TUNEL) staining
Twenty-four hours after the MCAO operation, the brain tissues of rats in each group were selected and fixed with 4% formaldehyde. After conventional dehydration, the tissues were embedded in paraffin, sliced into 3-μm sections, and attached to polylysine-treated glass slides. After the sections were baked at 60°C for 1 h, they were dewaxed, placed in a plastic dyeing rack, and put into a Coplin jar containing 0.01 mol/l citrate buffer (pH 6.0). Then, the plastic Coplin jar was placed in a boiling water bath for 10 min, and the water depth was 3 cm away from the top of the plastic Coplin jar. Then, the power was turned off, and the sections were kept warm for 20 min and cooled at room temperature after removal from the dyeing vat. Samples were rinsed with PBS, and DNA sections were labeled. The remaining operations were conducted in accordance with the instructions for the TUNEL kit (Boehringer Mannheim Company, Beijing, China). The experimental results indicated the number of cells with apoptotic nuclei and the total number of cells under high-power views (6 non-overlapping, high-power views were randomly selected in each slice). The apoptotic index (AI) was the number of apoptotic nuclei in 100 nuclei. AI = TUNEL positive cells/total cells × 100%. The experiment was repeated three times, and the mean value of each experiment was calculated.
Microtubule-associated protein 2 (MAP2) staining
The ischemic brain tissue was collected and cut into 1-mm 3 pieces, which were homogenized and digested with trypsin and collagenase. The particulates were removed with 200 mesh screens, and 2 ml of 10% Dulbecco's minimum essential medium (DMEM) high glucose solution (319-020-CL; Wisent Biological Technology Co., Ltd., Nanjing, China) was added into the cell suspension. After the cell suspension was obtained, the cell concentration was adjusted to 1 × 10 6 cells/ml, and cells were inoculated in a culture plate. After 40 h, 5 μg/ml cytarabine was added to the medium to inhibit the growth of glial cells. After 5 d of continuous culture, neuron-specific MAP2 protein staining was used to identify neuron purity. Immunofluorescent staining was performed after culturing neurons for 5 d. After removal of the culture medium and once the neurons were cultured for 7 d, immunofluorescence staining was performed. The neurons were washed with 0.01 mol/l PBS 3 times for 5 min, fixed with 4% precooled PFA for 30 min, washed with 0.01 mol/l PBS 3 times for 5 min, and sealed with 10% normal goat serum at room temperature for 1 h to block nonspecific antibody binding sites. The culture medium was removed, and the rabbit anti-MAP2 primary antibody prepared with 10% normal goat serum (1:200, ab32454, Abcam Inc., Cambridge, MA, USA) was added to the neurons, which were shaken and incubated at 4°C for at least 16 h. The neurons were washed with 0.01 mol/l PBS 3 times for 5 min, and the goat anti-rabbit fluorescence secondary antibody (1:500) was added for incubation at 37°C in the dark for 30 min. The neurons were washed with 0.01 mol/l PBS 3 times for 5 min and mounted with 70% glycerol phosphate buffer solution. The percentage of MAP2-positive cells in the total number of cells was counted by an inverted fluorescence microscope (IX73, Olympus, Tokyo, Japan).
Flow cytometry
The cell concentration was adjusted to 1.25 × 10 6 cells/ml, and cells were stained with propidium iodide (PI) for 10 min. The tests were carried out in accordance with the Annexin V-FITC flow cytometry kit (40302ES20, Shanghai Qcbio Science & Technologies Co., Ltd., Shanghai, China), and cell apoptosis was evaluated within 1 h using a FACSCalibur flow cytometer (342975, BD, Franklin Lakes, New Jersey, USA). A total of 1 × 10 4 cells were counted in each sample by an excitation wavelength of 488 nm, and the measurement data were analyzed by Cell Quest software. The experiment was repeated 3 times.
Immunofluorescence
Coronal sections were sliced continuously using the -20°C cryostat; the thickness was approximately 40 μm. A total of 6 sections in each group underwent immunofluorescence staining of newly generated neurons double labeled with 5-bromo-2-deoxyuridine (BrdU)/NeuN in the hippocampus. Afterwards, sections were incubated in a water bath for 2 h with 50% formamide solution (0.02 mol/l citrate buffer, pH 6.0) at 65°C for antigen retrieval. Then, the samples were incubated in a water bath with 2 mol/l of HCl at 
Enzyme-linked immunosorbent assay (ELISA)
The rats were intraperitoneally injected with 2% pentobarbital sodium (WS20051129, Sinopharm Chemical Reagent Co., Ltd., Shanghai, China), and 4 ~ 5 ml of blood was extracted from the abdominal aorta, placed at room temperature for 30 min, and centrifuged at 3500 r/min for 15 min to separate the serum. The assay was performed strictly in accordance with the instructions of the tumor necrosis factor-α (TNF-α) ELISA kit (ab46070), interleukin-1β (IL-1β) ELISA kit (ab100768), IL-6 ELISA kit (ab100772), IL-10 ELISA kit (ab100764) and nerve growth factor (NGF) ELISA kit (ab193736) purchased from Abcam Inc. (Cambridge, MA, USA) and the neurite outgrowth inhibitor -A (Nogo-A) ELISA kit (CSB-EQ027219RA, Shanghai Gaochuang Chemical Co., Ltd., Shanghai, China). The ELISA kit was balanced at room temperature for 20 min. After the standard substances were dissolved, 100 μl was added into the reaction plate to draw the standard curve. A total of 100 μl of sample was added to the reaction well, followed by incubation at 37°C for 90 min and 5 washes at intervals of 30 s. Then, 100 μl of fresh biotinylated antibody working fluid was added, followed by incubation at 37°C for 1 h and 5 washes at intervals of 30 s. After the washes, 100 μl of fresh enzyme-bound reactant working fluid was added away from light, followed by another incubation at 37°C for 30 min and 5 washes. Then, stop buffer was swiftly added to terminate the reaction. The optical density (OD) value of each well was determined at the wavelength of 450 nm using a microplate reader (ELx800, Bio-TEK Instruments Inc., VT, USA) within 3 min. The standard curve was drawn according to the OD value, and the contents of inflammatory factors (TNF-α, IL-1β, IL-6 and IL-10), NGF and Nogo-A were evaluated. The experiment was repeated 3 times.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
Total RNA in brain tissue was extracted according to TRIzol reagent instructions (15596-026, Invitrogen Inc., Carlsbad, CA, USA). Ultrapure water with diethylpyrocarbonate (DEPC, DB0154, Shanghai Sangon Biotech Co., Ltd., Shanghai, China) was used to dissolve RNA. The OD values at 260 nm and 280 nm were measured by a ND-1000 ultraviolet (UV)/visible spectrophotometer (ND-1000, Thermo Fisher Scientific Inc., Waltham, MA, USA) to identify the quality of the total RNA and determine its concentration. Reverse transcription of the extracted RNA was performed based on the kit (RR037Q, TaKaRa Biotechnology Co., Ltd., Dalian, China) by using a two-step method. Reverse transcription system: [27] . Each group had 3 replicates, and the mean value of each experiment was calculated.
Western blotting
Here, 3 ml of lysate buffer (mixed with 7 mol/l urea, 2 mol/l thiourea, 5 ml/l immobilized pH gradient (IPG) buffer (pH 3 ~ 10), 65 mmol/l dithiothreitol (DTT), 40 g/l CHAPS, 5 mg/l protease inhibitor and 10 mg/l trypsin inhibitor) was added to the brain tissue, which was then smashed by ultrasound on ice. After centrifugation with 120, 000 g at 4°C for 30 min, the supernatant was collected, and the protein concentration was determined by bicinchoninic acid (BCA) assay. Then, 5 × sodium dodecyl sulfate (SDS) lysate buffer was added to the sample (P0013G; Beyotime Biotechnology Co., Ltd., Beijing, China), which was boiled at 100°C for 5 min. Then, 20 μl of the sample was uploaded and separated using polyacrylamide gel electrophoresis (5% concentration gel and 12% separation gel). After the membrane was transferred, samples were blocked with tris-buffered saline Tween-20 (TBST) containing 5% bovine serum albumin (BSA) for 1 h at room temperature. Then, the sealing liquid was discarded, and 5% BSA was added to the membrane to prepare for the addition of the primary antibodies rabbit anti-LRRC4 (ab121283, 1:500), rabbit anti-SDF-1 (ab9797, 1:5000), rabbit anti-CXCR4 (ab13854, 1:1000), rabbit anti-Slit2 (ab7665, 1:1000), rabbit anti-vascular endothelial growth factor (VEGF) (ab9546, 1:500 ), rabbit anti-extracellular signal-regulated kinase (ERK) 1/2 (ab79853, 1:5000), rabbit anti-pERK1/2 (ab76299, 1:5000) and rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (ab181602, 1:10000) purchased from Abcam Inc. (Cambridge, MA, USA). Then, the membranes were placed in the refrigerator overnight at 4°C with the transferred membrane face up. The next day, samples were washed 3 times with TBST, each time for 10 min, and diluted goat anti-rabbit secondary antibody was added using the same method (1:10000, ab6721, Abcam Inc., Cambridge, MA, USA). After incubation at 4°C for 4 ~ 6 h, samples were washed with TBST 3 times again, each time for 15 min. The ultrasensitive chemiluminescence reagents A solution and B solution (Shanghai Yanhui Biotechnology Co., Ltd., Shanghai, China) were mixed at a 1:1 ratio, uniformly added to the nitrocellulose filter (NC) membrane, and developed with developer solution. All band patterns were analyzed with relative densitometric analysis. Each group had 3 replicates, and the mean value of each experiment was calculated.
Statistical analysis
The statistical analysis was conducted using SPSS 21.0 software (SPSS Inc. Chicago, IL, USA). The measurement data were presented as the means ± standard deviation (SD). One-way analysis of variance (ANOVA) was used for comparisons among multiple groups. Comparisons between two groups were analyzed using the t test. P < 0.05 was considered statistically significant.
Results
LRRC4 is a target gene of miR-381
Through the online analysis software, a specific binding region between the 3'-UTR region of LRRC4 and the miR-381 sequence was identified, indicating that LRRC4 was the
target gene of miR-381. Dual luciferase reporter gene assays revealed that miRNA-381 mimic had no effect on the luciferase activity of LRRC4-3'-UTR-mut (P > 0.05) but decreased the luciferase activity of LRRC4-3'-UTR-wt (P < 0.05), which indicated that miR-381 can specifically bind to LRRC4-3'-UTR (Fig. 1) .
Identification of rat models and neurological function scores of rats A total of 8 rats was used to establish the model of MCAO, and 40 rats were used for the CLB + MCAO model. After modeling, the Zea Longa score was used for the behavioral score. A total of 6 MCAO rats and 30 CLB + MCAO rats with scores of 2 ~ 3 were selected for follow-up experiments ( Table 2) .
Twenty-four hours after the MCAO operation, the mNSS of the rats in each group was analyzed. Compared with the sham group, the other groups had significantly increased mNSSs (P < 0.05). Compared with the mNSS of the MCAO group, the mNSS of the CLB + MCAO + miR-381 mimic group was decreased significantly (P < 0.05), indicating that the neurological damage was alleviated, while the mNSSs of the other four groups were significantly increased (P < 0.05), reflecting that the neurological damage was more serious. Compared with the mNSS of the CLB + MCAO group, the mNSSs of the CLB + MCAO + miR-381 inhibitor group and the CLB + MCAO + AMD3100 group were significantly increased (P < 0.05), indicating that the neurologic damage was more serious, and there were no significant differences between the mNSSs of the CLB + MCAO + miR-381 inhibitor group and the CLB + MCAO + AMD3100 group (P > 0.05). The score of the CLB + MCAO + miR-381 mimic group decreased significantly compared to that of the CLB + MCAO group (P < 0.05), which revealed that the neurological damage was relieved, and there was no significant difference between the mNSSs of the CLB + MCAO + miR-381 mimic group and the CLB + MCAO + miR-381 mimic + AMD3100 group (P > 0.05) ( Table 3) .
Up-regulation of miR-381 and down-regulation of LRRC4 reduce cerebral infarction volume
The cerebral infarction volume of rats was determined by TTC staining (Fig. 2) : the normal brain tissue was dyed red, and the necrotic brain tissue was dyed white. Compared with the sham group, the other groups had a significantly elevated cerebral infarction 
M o r p h o l o g i c a l changes of rat neurons in each group
In the sham group, the cells in the hippocampus were arranged evenly, with uniform size and complete structure, and the nerve cells were plump without obvious abnormalities. Cells in the rat hippocampus of the MCAO group were disorderly arranged, and cell shrinkage, karyopyknosis, anachromasis, and cell membranes with distinct boundaries were observed. In the CLB + MCAO group and the CLB + MCAO + miR-381 mimic + AMD3100 group, cells in the rat hippocampus were disorderly arranged, and cell shrinkage and deformation, chromatin condensation, partial nuclear fragmentation and some neurons with vacuoles were observed. The CLB + MCAO + miR-381 inhibitor group and the CLB + MCAO + AMD3100 group presented cell shrinkage and deformation and nuclear fragmentation, and there were more neurons with vacuoles. However, cells of the CLB + MCAO + miR-381 mimic group were arranged regularly with uniform size and complete structure, and slight shrinkage and light staining were observed (Fig. 3) .
Up-regulation of miR-381 and down-regulation of LRRC4 reduce cell apoptosis
The cell apoptosis of rats was evaluated by TUNEL staining (Fig. 4) . Compared with the sham group, the other groups had significantly elevated apoptosis rates (P < 0.05). Compared with the apoptosis rate in the MCAO group, the cell apoptosis rate in the CLB + MCAO + miR-381 mimic group was decreased significantly (P < 0.05), and the rates in the other four groups were increased significantly (P < 0.05). Compared with the apoptosis rates in the CLB + MCAO group, the cell apoptosis rates in the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups were increased significantly (P < 0.05), but there were no significant differences between the rates in the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups (P > 0.05). The cell apoptosis rate of the CLB + MCAO + miR-381 mimic group was decreased compared to that of the CLB + MCAO group (P < 0.05), while there was no significant difference in the apoptosis rate of the CLB + MCAO + miR-381 mimic + AMD3100 group (P > 0.05). Compared with the CLB + MCAO + AMD3100 group, the CLB + MCAO + miR-381 mimic + AMD3100 group had a lower apoptosis rate (P < 0.05).
Up-regulation of
miR-381 and downregulation of LRRC4 decrease n e u r o n a l apoptosis Before flow cytometry, the purity of neurons was first identified. The purity of neurons was above 93%, indicating that few glial cells interfered with the experimental results.
Neuronal apoptosis in rats was evaluated using flow cytometry (Fig. 5) . Compared with the sham group, the other groups had significantly elevated neuronal apoptosis rates (P < 0.05). Compared with the neuronal apoptosis rate of the MCAO group, the neuronal apoptosis rate of the CLB + MCAO + miR-381 mimic group was decreased significantly (P < 0.05), and the rates in other groups were significantly increased (P < 0.05). Compared with the rate in the CLB + MCAO group, the neuronal apoptosis rates of the CLB + MCAO + AMD3100 inhibitor group and CLB + MCAO + AMD3100 group were higher (P < 0.05), but the rates of the CLB + MCAO + miR-381 inhibitor group and the CLB+MCAO+AMD3100 group were not significantly different (P > 0.05). The neuronal apoptosis rate was significantly decreased in the CLB + MCAO + miR-381 mimic group compared with that in the CLB + MCAO group (P < 0.05), while the rate of the CLB + MCAO + miR-381 mimic + AMD3100 group was not significantly different (P > 0.05). Compared with the CLB + MCAO + AMD3100 group, the CLB + MCAO + miR-381 mimic + AMD3100 group had a lower neuronal apoptosis rate (P < 0.05).
BrdU-positive expression of rats in each group
The BrdU-positive expression of rats in each group was determined by immunohistochemical staining (seen in Fig. 6 ). BrdU/NeuN double-positive cells were yellow. Compared with the sham group, the other groups had significantly decreased 
Contents of TNF-α, IL-1β, IL-6, IL-10, NGF and Nogo-A in each group of rats
ELISA was used to measure the contents of inflammatory factors (TNF-α, IL-1β, IL-6 and IL-10), NGF and Nogo-A in serum (Fig. 7) . Compared with the sham group, the other groups had significantly increased contents of TNF-α, IL-1β, IL-6 and Nogo-A but decreased contents of IL-10 and NGF (all P < 0.05). Compared with the levels in the MCAO group, the contents of TNF-α, IL-1β, IL-6 and Nogo-A in the CLB + MCAO + miR-381 mimic group were significantly decreased, but the contents of IL-10 and NGF were significantly increased (all P < 0.05). The contents of TNF-α, IL-1β, IL-6 and Nogo-A in the other four groups were significantly increased, and IL-10 and NGF were significantly decreased compared to those in the CLB + MCAO group (all P < 0.05). Compared with the levels in the CLB + MCAO group, the contents of TNF-α, IL-1β, IL-6 and Nogo-A were significantly increased in the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups, and IL-10 and NGF were significantly decreased (all P < 0.05). There was no remarkable difference in serum levels between the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups (P > 0.05). The contents of TNF-α, IL-1β, IL-6 and Nogo-A in the CLB + MCAO + miR-381 mimic group were obviously decreased, and the levels of IL-10 and NGF were significantly increased compared to those in the CLB + MCAO group (all P < 0.05). The contents of TNF-α, IL-1β, IL-6, IL-10 and Nogo-A in the CLB + MCAO + miR-381 mimic + AMD3100 group were not significantly different from those in the CLB + MCAO group (all P > 0.05). Compared with the CLB + MCAO + AMD3100 group, the CLB + MCAO + miR-381 mimic + AMD3100 group had reduced contents of TNF-α, IL-1β, IL-6 and Nogo-A but elevated contents of IL-10 and NGF (all P < 0.05).
miR-381 expression and LRRC4, SDF-1, CXCR4, ERK, Slit2 and VEGF mRNA expression in rat brain tissues from each group
RT-qPCR was performed to measure the expression levels of miR-381, LRRC4, SDF-1, CXCR4, ERK, Slit2 and VEGF in brain tissues of rats (Fig. 8) . Compared with the sham group, the other groups had significantly reduced miR-381 expression and SDF-1, CXCR4, ERK, Slit2 and VEGF mRNA expression but elevated LRRC4 mRNA expression (all P < 0.05). Compared with the expression in the MCAO group, miR-381 expression and SDF-1, CXCR4, ERK, Slit2 and VEGF mRNA expression in the CLB + MCAO + miR-381 mimic group were significantly increased, but LRRC4 mRNA expression was obviously decreased (all P < 0.05). miR-381 expression and LRRC4 mRNA expression were significantly increased in the CLB + MCAO + miR-381 mimic + AMD3100 group, while the mRNA expression of SDF-1, CXCR4, ERK, Slit2 and VEGF were decreased compared with that in the CLB + MCAO group (all P < 0.05). miR-381 expression and SDF-1, CXCR4, ERK, Slit2 and VEGF mRNA expression in the other three groups were remarkably decreased (all P < 0.05), but LRRC4 mRNA expression was obviously increased compared with that in the CLB + MCAO group (P < 0.05). Compared with the expression in the CLB + MCAO group, the mRNA expression of SDF-1, CXCR4, ERK, Slit2 and VEGF was decreased in the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups (all P < 0.05), but the mRNA expression of LRRC4 was increased (P < 0.05). Compared with the expression in the CLB + MCAO group, miR-381 expression was decreased in the CLB + MCAO + miR-381 inhibitor group (P < 0.05), but no significant difference was found in the CLB + MCAO + AMD3100 group (P > 0.05). miR-381 expression and SDF-1, CXCR4, ERK, Slit2 and VEGF expression in the CLB + MCAO + miR-381 mimic group were significantly increased (all P < 0.05), but LRRC4 mRNA expression was significantly decreased compared with that in the CLB + MCAO group (P < 0.05). The expression of miR-381 was significantly increased in the CLB + MCAO + miR-381 mimic + AMD3100 group, while the mRNA expression of LRRC4, SDF-1, CXCR4, ERK, Slit2 and VEGF was not significantly different than that in the CLB + MCAO group (all P > 0.05). Compared with the CLB + MCAO + AMD3100 group, the CLB + MCAO + miR-381 mimic + AMD3100 group had elevated miR-381 expression and SDF-1, CXCR4, ERK, Slit2 and VEGF mRNA expression but reduced LRRC4 mRNA expression (all P < 0.05).
Protein expression of LRRC4, SDF-1, CXCR4, ERK, Slit2 and VEGF in rat brain tissues in each group
The protein expression of LRRC4, SDF-1, CXCR4, ERK, Slit2 and VEGF in the brain tissue of rats was determined by Western blotting (Fig. 9) . Compared with the sham group, the other groups had significantly reduced SDF-1, CXCR4, ERK, Slit2 and VEGF protein expression but elevated LRRC4 protein expression (all P < 0.05). Compared with the protein expression in the MCAO group, the protein expression of SDF-1, CXCR4, ERK, Slit2 and VEGF in the CLB + MCAO + miR-381 mimic group was remarkably increased (all P < 0.05), but LRRC4 protein expression was obviously decreased (P < 0.05). The protein expression of SDF-1, CXCR4, ERK, Slit2 and VEGF in the other four groups was significantly decreased (all P < 0.05), but LRRC4 expression was obviously increased compared with that in the CLB + MCAO group (P < 0.05). There was no significant difference in protein expression between the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups, and the protein expression of SDF- 1, CXCR4, ERK, Slit2 and VEGF in the CLB + MCAO + miR-381 mimic group was remarkably increased (all P < 0.05), but LRRC4 expression was obviously decreased compared with that in the CLB + MCAO group (P < 0.05). The protein expression of SDF-1, CXCR4, ERK, Slit2 and VEGF in the CLB + MCAO + miR-381 mimic + AMD3100 group was not significantly different from that in the CLB + MCAO group (all P > 0.05). Compared with the CLB + MCAO + AMD3100 group, the CLB + MCAO + miR-381 mimic + AMD3100 group had elevated SDF-1, CXCR4, ERK, Slit2 and VEGF protein expression but reduced LRRC4 protein expression (all P < 0.05).
Discussion
It is well known that neurological damage caused by focal or global cerebral ischemia is the main cause of adult death and disability [28] . Ischemic brain injury, known as ischemic stroke, is caused by occlusion of a blood vessel, and the remarkable decrease in regional cerebral blood flow leads to hypoxia, glucose loss and brain damage [29] . Recent experiments demonstrated that ischemia-induced miRs act as negative regulators of genes, taking part in the treatment for acute and chronic ischemia [30, 31] . In this study, we investigated the effect of miR-381 targeting LRRC4 by the SDF-1/CXCR4 signaling pathway on the repair of nerve injury in rats with acute cerebral ischemia after CLB.
Initially, our results found that compared with the CLB + MCAO group, the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups showed significantly increased mNSSs and a larger infarction volume, while the CLB + MCAO + miR-381 mimic group showed the opposite tendency, which indicated that up-regulation of miR-381 and downregulation of LRRC4 can alleviate the neurologic damage and cerebral infarction volume. Abnormally expressed miRs have been proven to play an important part in diagnosis, prognosis and prediction of treatment outcome [32] . As previously reported, miR-9a-5p may provide a promising target in alleviating MCAO-induced ischemia injury; down-regulation of miR-147 was responsible for the aggravation of hypoxial injury in PC12 cells [33, 34] . Stable hsa-miR-381 expression in serum was suggested to offer a new and prospective diagnostic biomarker, and anti-hsa-miR-381 could be an ideal target for glioma treatment, further indicating that miR-381 could participate in the activities of the nervous system [15] . Another study revealed that neurologic damage often occurs in susceptible brain regions, for example, the hippocampus and the cerebral cortex, which verified that the neuronal cell death was associated with ischemia [26] .
Additionally, our results found that compared with the CLB + MCAO group, the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups showed significantly increased apoptosis rates, and the CLB + MCAO + miR-381 mimic group showed the opposite tendency, which indicated that up-regulation of miR-381 and down-regulation of LRRC4 inhibited neuronal apoptosis. The previous study showed that LRRC4, as a major glioma suppressor, suppressed glioma cell proliferation and growth, but recently, we found that leucine-rich repeat-containing G protein-coupled receptor 4, which comes from the same family as LRRC4, inhibited apoptosis induced by miR, which suggested that cell apoptosis could be influenced by LRRC4 [35, 36] . A relevant study demonstrated that the up-regulation of miR-30 could aid in suppressing neuronal cell death in cerebral ischemic stroke [37] . It is reported that miR-93 can repress apoptosis after cerebral ischemia via interleukin-1 [38] . Similarly, a previous study proved that miR-381 was overexpressed in the mature brain and normal hippocampal neurons [13] , and decreasing miR-381 expression inhibited cell proliferation and invasion [39, 40] , from which we inferred that up-regulation of miR-381 inhibited neuronal apoptosis.
Consequently, our study revealed that compared with the CLB + MCAO group, the CLB + MCAO + miR-381 inhibitor and CLB + MCAO + AMD3100 groups showed significantly increased levels of TNF-α, IL-1β, IL-6 and Nogo-A and expression of LRRC4 but decreased contents of NGF and IL-10 and expression of SDF-1 and CXCR4 in brain tissues, which indicated that up-regulation of miR-381 negatively targeting LRRC4 activated the SDF-1/ CXCR4 signaling pathway. LRRC4 appeared to be specifically expressed in the LRR protein superfamily and brain tissues and, importantly, plays a key role in tumor suppression in the pathogenesis of malignant gliomas [41] . In line with our study, a relevant study indicated that LRRC4 was a target gene of miR-381, and silencing miR-381 inhibited cell proliferation and glioma cell growth, which may suggest that miR-381 was involved in brain disease [14] . Wu et al. provided evidence that LRRC4 inhibited some growth factors, cytokines and their receptors, as well as the ability of glioma cells to stimulate cytokines, resulting in the proliferation inhibition of glioma [42] . SDF-1α is a small molecule that shows an increased expression under hypoxia and ischemia, and CXCR4 is its receptor [43] . SDF-1α binds to its receptor CXCR4 and activates a variety of signal transduction pathways to regulate cell migration and proliferation; LRRC4 can regulate the SDF-1α/CXCR4 signaling pathway in glioblastoma, which indicated that LRRC4 can activate SDF-1α/CXCR4 to enhance proliferation to repair cell injury [44] .
In conclusion, our study demonstrates that up-regulation of miR-381 suppressed LRRC4, which activated the SDF-1/CXCR4 signaling pathway to reduce nerve injury and neuronal apoptosis. Nevertheless, there are few studies on the repair of nerve injury in rats with acute cerebral ischemia after CLB. Further research should be conducted into these treatments as potential options for the management of acute cerebral ischemia among humans, and additional mechanistic evidence is required for these potential treatments.
